Goal Vest Advisory LLC Sorrento Therapeutics, Inc. Transaction History

Goal Vest Advisory LLC

  • $309 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 03, 2023
SELL
$0.17 - $1.19 $3,183 - $22,282
-18,725 Reduced 36.26%
32,915 $12,000
Q4 2022

Jan 06, 2023
BUY
$0.74 - $1.83 $13,338 - $32,985
18,025 Added 53.62%
51,640 $0
Q3 2022

Oct 11, 2022
BUY
$1.51 - $2.88 $50,758 - $96,811
33,615 New
33,615 $53,000

Others Institutions Holding SRNE

# of Institutions
13
Shares Held
5.48M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Goal Vest Advisory LLC Portfolio

Follow Goal Vest Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goal Vest Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goal Vest Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email